97 results
Page 2 of 5
8-K
EX-99.1
bdpjhrqzlz 20bd5kmyu
24 Feb 22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:27pm
8-K
EX-99.1
vn01l1htf3c3o4bc2 h1
4 Nov 21
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:07pm
8-K
EX-99.2
ryxpszej
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
gib4p
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.1
lrn6v1bgpl
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
t4un7sl
24 May 21
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-99.1
8jv6i0579lyvr88d3
21 May 21
CORRECTION — EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s
3:38pm
8-K
EX-99.1
f75qzhwvocgeea6i2
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm
8-K
EX-99.1
zvrdu9jx0skbkw
13 Apr 21
Other Events
4:06pm
8-K
EX-99.1
zu8oh8 ke
25 Feb 21
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:15pm
8-K
1dr8byagxb6sb
19 Feb 21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
5:03pm